{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:30:21Z","timestamp":1772742621149,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007533","name":"Kobayashi Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1002\/jps.24686","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T21:46:57Z","timestamp":1446500817000},"page":"734-740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Validation of a Strategy for Cancer Therapy: Delivering Aminoglycoside Drugs to Mitochondria in HeLa Cells"],"prefix":"10.1016","volume":"105","author":[{"given":"Jiro","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuma","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyoshi","family":"Harashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1002\/jps.24686_bib1","first-page":"773","article-title":"Pay dirt: The story of streptomycin. Part I. From Waksman to Waksman","volume":"117","author":"Comroe","year":"1978","journal-title":"Am Rev Respir Dis"},{"issue":"192","key":"10.1002\/jps.24686_bib2","doi-asserted-by":"crossref","first-page":"192ra185","DOI":"10.1126\/scitranslmed.3006055","article-title":"Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in Mammalian cells","volume":"5","author":"Kalghatgi","year":"2013","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1002\/jps.24686_bib3","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1681\/ASN.2004080631","article-title":"Aminoglycosides induce acute cell signaling and chronic cell death in renal cells that express the calcium-sensing receptor","volume":"16","author":"Ward","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1002\/jps.24686_bib4","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1128\/AAC.00965-08","article-title":"Interaction of aminoglycosides with human mitochondrial 12S rRNA carrying the deafness-associated mutation","volume":"53","author":"Qian","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1002\/jps.24686_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jpeds.2013.10.024","article-title":"Mitochondrial 12S ribosomal RNA A1555G mutation associated with cardiomyopathy and hearing loss following high-dose chemotherapy and repeated aminoglycoside exposure","volume":"164","author":"Skou","year":"2014","journal-title":"J\u00a0Pediatr"},{"issue":"5876","key":"10.1002\/jps.24686_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.1156906","article-title":"ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis","volume":"320","author":"Ishikawa","year":"2008","journal-title":"Science"},{"issue":"2","key":"10.1002\/jps.24686_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1172\/JCI80420","article-title":"Targeting the extrinsic apoptotic pathway in cancer: Lessons learned and future directions","volume":"125","author":"Ashkenazi","year":"2015","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1002\/jps.24686_bib8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1021\/cb400095v","article-title":"Targeted delivery of doxorubicin to mitochondria","volume":"8","author":"Chamberlain","year":"2013","journal-title":"ACS Chem Biol"},{"issue":"2","key":"10.1002\/jps.24686_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10162-009-0160-4","article-title":"Trafficking of systemic fluorescent gentamicin into the cochlea and hair cells","volume":"10","author":"Wang","year":"2009","journal-title":"J\u00a0Assoc Res Otolaryngol"},{"key":"10.1002\/jps.24686_bib10","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1038\/emm.2013.25","article-title":"Different uptake of gentamicin through TRPV1 and TRPV4 channels determines cochlear hair cell vulnerability","volume":"45","author":"Lee","year":"2013","journal-title":"Exp Mol Med"},{"issue":"2","key":"10.1002\/jps.24686_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbamem.2007.11.002","article-title":"MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion","volume":"1778","author":"Yamada","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"13-14","key":"10.1002\/jps.24686_bib12","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.addr.2008.04.016","article-title":"Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases","volume":"60","author":"Yamada","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.24686_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biomaterials.2015.04.022","article-title":"Mitochondrial delivery of antisense RNA by MITO-Porter results in mitochondrial RNA knockdown, and has a functional impact on mitochondria","volume":"57","author":"Furukawa","year":"2015","journal-title":"Biomaterials"},{"key":"10.1002\/jps.24686_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4939-2288-8_10","article-title":"Targeting the mitochondrial genome via a dual function MITO-Porter: Evaluation of mtDNA levels and mitochondrial function","volume":"1265","author":"Yamada","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"8","key":"10.1002\/jps.24686_bib15","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1074\/jbc.M007540200","article-title":"Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery","volume":"276","author":"Futaki","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1002\/jps.24686_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ymthe.2004.08.010","article-title":"Cellular uptake of arginine-rich peptides: Roles for macropinocytosis and actin rearrangement","volume":"10","author":"Nakase","year":"2004","journal-title":"Mol Ther"},{"issue":"6 Pt 1","key":"10.1002\/jps.24686_bib17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/clinchem\/46.6.837","article-title":"Determination of gentamicins C(1), C(1a), and C(2) in plasma and urine by HPLC","volume":"46","author":"Isoherranen","year":"2000","journal-title":"Clin Chem"},{"issue":"9","key":"10.1002\/jps.24686_bib18","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.75.9.4194","article-title":"Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation","volume":"75","author":"Szoka","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1002\/jps.24686_bib19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s11051-012-1013-3","article-title":"Mitochondrial-targeted DNA delivery using a DF-MITO-Porter, an innovative nano carrier with cytoplasmic and mitochondrial fusogenic envelopes","volume":"14","author":"Yamada","year":"2012","journal-title":"J\u00a0Nanopart Res"},{"issue":"5","key":"10.1002\/jps.24686_bib20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jbiosc.2013.05.001","article-title":"Intracellular observation of nanocarriers modified with a mitochondrial targeting signal peptide","volume":"116","author":"Kawamura","year":"2013","journal-title":"J\u00a0Biosci Bioeng"},{"issue":"4","key":"10.1002\/jps.24686_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/AAC.17.4.544","article-title":"Preparation and properties of liposome-associated gentamicin","volume":"17","author":"Morgan","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1002\/jps.24686_bib22","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1074\/jbc.M111.316315","article-title":"Axonal neuropathy-associated TRPV4 regulates neurotrophic factor-derived axonal growth","volume":"287","author":"Jang","year":"2012","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1002\/jps.24686_bib23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/jps.23442","article-title":"Mitochondrial delivery of bongkrekic acid using a MITO-porter prevents the induction of apoptosis in human hela cells","volume":"102","author":"Yamada","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"issue":"9","key":"10.1002\/jps.24686_bib24","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1073\/pnas.0707265105","article-title":"Mitochondrial deafness alleles confer misreading of the genetic code","volume":"105","author":"Hobbie","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1002\/jps.24686_bib25","doi-asserted-by":"crossref","first-page":"e38471","DOI":"10.1371\/journal.pone.0038471","article-title":"Gentamicin rapidly inhibits mitochondrial metabolism in high-frequency cochlear outer hair cells","volume":"7","author":"Jensen-Smith","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1002\/jps.24686_bib26","doi-asserted-by":"crossref","first-page":"e22347","DOI":"10.1371\/journal.pone.0022347","article-title":"Functional hair cell mechanotransducer channels are required for aminoglycoside ototoxicity","volume":"6","author":"Alharazneh","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1002\/jps.24686_bib27","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jjco\/hyl109","article-title":"Phase 1 clinical study of pegylated liposomal doxorubicin (JNS002) in Japanese patients with solid tumors","volume":"36","author":"Fujisaka","year":"2006","journal-title":"Jpn J Clin Oncol"},{"issue":"14","key":"10.1002\/jps.24686_bib28","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.addr.2010.07.011","article-title":"Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells","volume":"62","author":"Dolman","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10.1002\/jps.24686_bib29","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/AAC.45.12.3487-3496.2001","article-title":"Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: Maximum tolerated dose study","volume":"45","author":"Walsh","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1002\/jps.24686_bib30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12033-010-9321-2","article-title":"Multiple drug resistance mechanisms in cancer","volume":"46","author":"Baguley","year":"2010","journal-title":"Mol Biotechnol"},{"issue":"1","key":"10.1002\/jps.24686_bib31","first-page":"45","article-title":"P-glycoprotein inhibitors of natural origin as potential tumor chemosensitizers: A review","volume":"6","author":"Abdallah","year":"2015","journal-title":"J\u00a0Adv Res"},{"issue":"12 Pt 1","key":"10.1002\/jps.24686_bib32","first-page":"6387","article-title":"A\u00a0new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res"},{"issue":"1-3","key":"10.1002\/jps.24686_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0168-3659(01)00309-1","article-title":"Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS","volume":"74","author":"Maeda","year":"2001","journal-title":"J\u00a0Control Release"},{"issue":"6","key":"10.1002\/jps.24686_bib34","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1248\/bpb.b13-00059","article-title":"The polyethyleneglycol dilemma: Advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors","volume":"36","author":"Hatakeyama","year":"2013","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"10.1002\/jps.24686_bib35","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1021\/nn305791q","article-title":"RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors","volume":"7","author":"Zhen","year":"2013","journal-title":"ACS Nano"},{"issue":"9","key":"10.1002\/jps.24686_bib36","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.1021\/nn4033954","article-title":"Enhanced cellular uptake of peptide-targeted nanoparticles through increased peptide hydrophilicity and optimized ethylene glycol peptide-linker length","volume":"7","author":"Stefanick","year":"2013","journal-title":"ACS Nano"},{"key":"10.1002\/jps.24686_bib37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jconrel.2015.05.003","article-title":"New trends in guided nanotherapies for digestive cancers: A systematic review","volume":"209","author":"Fernandes","year":"2015","journal-title":"J\u00a0Control Release"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491500115X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491500115X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:44:13Z","timestamp":1656031453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235491500115X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S002235491500115X"],"URL":"https:\/\/doi.org\/10.1002\/jps.24686","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of a Strategy for Cancer Therapy: Delivering Aminoglycoside Drugs to Mitochondria in HeLa Cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/jps.24686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}